FFCP PHASE2:Hg19::chr12:95867919..95867951,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@METAP2 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_METAP2_5end |
Coexpression cluster: | C3345_acute_hepatoblastoma_Myoblast_tridermal_Reticulocytes_seminal_neuroepithelioma |
Association with transcript: | 0bp_to_ENST00000261220, ENST00000549502, ENST00000550777, ENST00000551840, ENST00000553151_5end |
EntrezGene: | METAP2 |
HGNC: | 16672 |
UniProt: | G3XA91F8VSC4F8VRR3F8VQZ7F8VY03 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@METAP2 |
---|
0
500
1000
1500
2000
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 1.57e-34 | 235 |
disease of cellular proliferation | 2.81e-33 | 239 |
cell type cancer | 2.15e-20 | 143 |
organ system cancer | 2.83e-16 | 137 |
carcinoma | 9.70e-16 | 106 |
hematologic cancer | 5.31e-12 | 51 |
immune system cancer | 5.31e-12 | 51 |
leukemia | 3.48e-10 | 39 |
myeloid leukemia | 4.90e-10 | 31 |
germ cell and embryonal cancer | 3.68e-09 | 22 |
Showing 1 to 10 of 11 entries